Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance. / Kalsen, Anders; Hostrup, Morten; Bangsbo, Jens; Backer, Vibeke.

I: Scandinavian Journal of Medicine & Science in Sports, Bind 24, Nr. 5, 2014, s. 814-822.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Kalsen, A, Hostrup, M, Bangsbo, J & Backer, V 2014, 'Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance', Scandinavian Journal of Medicine & Science in Sports, bind 24, nr. 5, s. 814-822. https://doi.org/10.1111/sms.12096

APA

Kalsen, A., Hostrup, M., Bangsbo, J., & Backer, V. (2014). Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance. Scandinavian Journal of Medicine & Science in Sports, 24(5), 814-822. https://doi.org/10.1111/sms.12096

Vancouver

Kalsen A, Hostrup M, Bangsbo J, Backer V. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance. Scandinavian Journal of Medicine & Science in Sports. 2014;24(5):814-822. https://doi.org/10.1111/sms.12096

Author

Kalsen, Anders ; Hostrup, Morten ; Bangsbo, Jens ; Backer, Vibeke. / Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance. I: Scandinavian Journal of Medicine & Science in Sports. 2014 ; Bind 24, Nr. 5. s. 814-822.

Bibtex

@article{9e5de671aae14111a87421bc66118c09,
title = "Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance",
abstract = "There is a high prevalence of asthma and airway hyperresponsiveness (AHR) in elite athletes, which leads to a major use of beta2 -agonists. In a randomized double-blinded crossover study, we investigated the effects of combined inhalation of beta2 -agonists (salbutamol, formoterol, and salmeterol), in permitted doses within the World Anti-Doping Agency 2013 prohibited list, in elite swimmers with (AHR, n = 13) or without (non-AHR, n = 17) AHR. Maximal voluntary isometric contraction of m. quadriceps (MVC), sprint performance on a swim ergometer and performance in an exhaustive swim test at 110% of VO2max were determined. Venous plasma interleukin-6 (IL-6) and interleukin-8 (IL-8) were measured post-exercise. No improvement was observed in the exhaustive swim test, but swim ergometer sprint time was improved (P ",
author = "Anders Kalsen and Morten Hostrup and Jens Bangsbo and Vibeke Backer",
note = "CURIS 2014 NEXS 280",
year = "2014",
doi = "10.1111/sms.12096",
language = "English",
volume = "24",
pages = "814--822",
journal = "Scandinavian Journal of Medicine & Science in Sports",
issn = "0905-7188",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance

AU - Kalsen, Anders

AU - Hostrup, Morten

AU - Bangsbo, Jens

AU - Backer, Vibeke

N1 - CURIS 2014 NEXS 280

PY - 2014

Y1 - 2014

N2 - There is a high prevalence of asthma and airway hyperresponsiveness (AHR) in elite athletes, which leads to a major use of beta2 -agonists. In a randomized double-blinded crossover study, we investigated the effects of combined inhalation of beta2 -agonists (salbutamol, formoterol, and salmeterol), in permitted doses within the World Anti-Doping Agency 2013 prohibited list, in elite swimmers with (AHR, n = 13) or without (non-AHR, n = 17) AHR. Maximal voluntary isometric contraction of m. quadriceps (MVC), sprint performance on a swim ergometer and performance in an exhaustive swim test at 110% of VO2max were determined. Venous plasma interleukin-6 (IL-6) and interleukin-8 (IL-8) were measured post-exercise. No improvement was observed in the exhaustive swim test, but swim ergometer sprint time was improved (P 

AB - There is a high prevalence of asthma and airway hyperresponsiveness (AHR) in elite athletes, which leads to a major use of beta2 -agonists. In a randomized double-blinded crossover study, we investigated the effects of combined inhalation of beta2 -agonists (salbutamol, formoterol, and salmeterol), in permitted doses within the World Anti-Doping Agency 2013 prohibited list, in elite swimmers with (AHR, n = 13) or without (non-AHR, n = 17) AHR. Maximal voluntary isometric contraction of m. quadriceps (MVC), sprint performance on a swim ergometer and performance in an exhaustive swim test at 110% of VO2max were determined. Venous plasma interleukin-6 (IL-6) and interleukin-8 (IL-8) were measured post-exercise. No improvement was observed in the exhaustive swim test, but swim ergometer sprint time was improved (P 

U2 - 10.1111/sms.12096

DO - 10.1111/sms.12096

M3 - Journal article

C2 - 23834392

VL - 24

SP - 814

EP - 822

JO - Scandinavian Journal of Medicine & Science in Sports

JF - Scandinavian Journal of Medicine & Science in Sports

SN - 0905-7188

IS - 5

ER -

ID: 48841693